Croatian Drug Maker Pliva Turns to 9-Mo Net Loss of 107 Mln Kuna (15 Mln Euro) – Table

"Pliva reported total revenue of 3.537 million kuna for the first nine months ended 30 September 2008, a decrease of 1.393 million kuna compared to revenues of 4.929 million kuna in the prior year period," Pliva said in a statement.

In the same period of 2007 Pliva’s net income was boosted by one-off revenue from the transfer of ownership of Pliva's U.S. business to Barr and activities related to the divestment of some non-core or discontinued operations.  

Excluding intragroup sales to Barr and sales from the Italy and Spain operations that were sold in the last quarter of 2007, sales increased approximately 8% over prior year, primarily as a result of growth in our key markets of Russia, Poland and Germany, it added.

It issued the following details (in millions of kuna):

Pliva’s shares had not traded by 0950 GMT on Friday on the Zagreb bourse on Friday morning. They closed unchanged at 770 kuna on October 29. 

(1 euro=7.1415 Croatian kuna)